FDA On Use Of AI/ML In Drug Development: Five Key Takeaways | MoFo Life Sciences

On Wednesday, May 10, 2023, the Food and Drug Administration (FDA) announced the publication of a new discussion paper titled “Using Artificial Intelligence and Machine Learning in the...

Related Keywords

United Kingdom ,Canada , ,Cder Ai Steering Committee ,National Evaluation System ,Regulatory Agency ,Drug Development ,Technology Approaches For New Drugs ,Development Of Standards ,Drug Administration ,Health Canada ,Pilot Program ,National Institute For Standards ,Model Development ,Development Of Drug ,Mofo Life Sciences ,Mofo Life ,Artificial Intelligence ,Machine Learning ,Biological Products ,Beach Stage ,Growing Its Own Experience ,Innovative Science ,Technology Approaches ,New Drugs ,Informed Drug Development ,Evaluation System ,National Institute ,Federal Engagement ,Developing Technical Standards ,Related Tools ,Good Machine Learning Practices ,Identified Key Questions ,Led Governance ,